Roche Holding AG on Friday said a therapy it co-developed with Cambridge-based Blueprint Medicines Corp was approved by the U.S. health regulator for the treatment of patients with a type of non-small ...
A Phase 3 clinical trial testing pridopidine in people with ALS is expected to start enrolling patients in January.
Obstructive sleep apnoea (OSA) affects up to 1 billion people worldwide and is defined by repeated upper airway collapse ...
In The Lancet Gastroenterology & Hepatology, Elyse Thakur and colleagues1 present an update of their 2020 systematic review and network meta-analysis on the efficacy of behavioural therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback